296 related articles for article (PubMed ID: 29636047)
1. Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
Chen XM; Zhang WQ; Tian Y; Wang LF; Chen CC; Qiu CM
Cardiovasc Diabetol; 2018 Apr; 17(1):53. PubMed ID: 29636047
[TBL] [Abstract][Full Text] [Related]
2. Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
Anholm C; Kumarathurai P; Samkani A; Pedersen LR; Boston RC; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Diabetes Obes Metab; 2019 Aug; 21(8):2012-2016. PubMed ID: 31050161
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
Anholm C; Kumarathurai P; Pedersen LR; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Diabetes Obes Metab; 2017 Jun; 19(6):850-857. PubMed ID: 28124822
[TBL] [Abstract][Full Text] [Related]
5. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.
Miyazaki Y; Glass L; Triplitt C; Matsuda M; Cusi K; Mahankali A; Mahankali S; Mandarino LJ; DeFronzo RA
Diabetologia; 2001 Dec; 44(12):2210-9. PubMed ID: 11793023
[TBL] [Abstract][Full Text] [Related]
6. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
7. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.
Abbasi F; Chu JW; McLaughlin T; Lamendola C; Leary ET; Reaven GM
Metabolism; 2004 Feb; 53(2):159-64. PubMed ID: 14767866
[TBL] [Abstract][Full Text] [Related]
8. Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.
Mather KJ; Considine RV; Hamilton L; Patel NA; Mathias C; Territo W; Goodwill AG; Tune JD; Green MA; Hutchins GD
J Clin Endocrinol Metab; 2018 Sep; 103(9):3456-3465. PubMed ID: 30020461
[TBL] [Abstract][Full Text] [Related]
9. Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
RISE Consortium
Diabetes Care; 2019 Sep; 42(9):1742-1751. PubMed ID: 31178434
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
[TBL] [Abstract][Full Text] [Related]
11. The impact of acute elevation of non-esterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes.
McLachlan KA; Alford FP
Clin Endocrinol (Oxf); 2005 Jan; 62(1):79-84. PubMed ID: 15638874
[TBL] [Abstract][Full Text] [Related]
12. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
[TBL] [Abstract][Full Text] [Related]
13. [The effect of liraglutide in combination with human umbilical cord mesenchymal stem cells treatment on glucose metabolism and β cell function in type 2 diabetes mellitus].
Chen P; Huang Q; Xu XJ; Shao ZL; Huang LH; Yang XZ; Guo W; Li CM; Chen C
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):349-54. PubMed ID: 27143183
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
15. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S
Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228
[TBL] [Abstract][Full Text] [Related]
16. Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function.
Forst T; Michelson G; Ratter F; Weber MM; Anders S; Mitry M; Wilhelm B; Pfützner A
Diabet Med; 2012 Sep; 29(9):1115-8. PubMed ID: 22288732
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide ameliorates beta-cell function, alleviates oxidative stress and inhibits low grade inflammation in young patients with new-onset type 2 diabetes.
Zhang WQ; Tian Y; Chen XM; Wang LF; Chen CC; Qiu CM
Diabetol Metab Syndr; 2018; 10():91. PubMed ID: 30564288
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism.
Vestergaard H; Lund S; Pedersen O
J Intern Med; 2001 Nov; 250(5):406-14. PubMed ID: 11887975
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
Tian F; Zheng Z; Zhang D; He S; Shen J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
